Enliven Therapeutics GAAP EPS of -$0.36
What it means
- What to watch: This one turns on a concrete figure ($0.36); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $ELVN -5.21% in the latest session.
- Timing: It landed while New York slept, so the session change beside it belongs to a day that had already closed. Market holidays are not detected.
Where the stock stands
$ELVN last changed hands at $44.79, -5.21% on the session, 28% below its 52-week high of $62.32 and 203% above its low of $14.79 — a little above the middle of the range. Over the year it has ranged 322% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $ELVN page.
How much coverage it is getting
This is the only story Wook has logged on $ELVN in the last 30 days — a quiet name that just got a headline. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$ELVN earnings in 5 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
The $ELVN page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $ELVN sits from its high, or how this week's coverage stacks up.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $ELVN. It carried $0.36, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.